ISSN: 1838-7640Theranostics
Global reach, higher impact
Theranostics 2021; 11(3):1176. doi:10.7150/thno.55371 This issue Cite
Retraction
Retraction of “MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance”
Jinping Lu1,3*, Yuejin Li1*, Yuanzhong Wu2*, Shan Zhou1, Chaojun Duan1, Zigang Dong4, Tiebang Kang2 
, Faqing Tang1,3
1. Department of Clinical Laboratory, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, 410013, Changsha, China
2. State Key Laboratory of Oncology in South China and Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong, China
3. Department of Clinical Laboratory and Medical Research Center, Zhuhai Hospital, Jinan University, Zhuhai 519000, Guangdong, China
4. Hormel Institute, University of Minnesota, 801 16th Avenue NE, Austin, MN 55912
*Lu J, Li Y, and Wu Y contributed equally to this work.
Citation:
Lu J, Li Y, Wu Y, Zhou S, Duan C, Dong Z, Kang T, Tang F. Retraction of “MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance”. Theranostics 2021; 11(3):1176. doi:10.7150/thno.55371. https://www.thno.org/v11p1176.htm
Other stylesRetracted-article in Theranostics, Volume 8, 5289
The Editor-In-Chief of Theranostics, in consultation and agreement with the editorial board members, retracts the article “MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance” [1] on the basis of questions related to several figures. The concerns about the figures also raise questions about the conclusions within the paper.
References
1. Lu J, Li Y, Wu Y, Zhou S, Duan C, Dong Z, Kang T, Tang F. MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance. Theranostics. 2018;8(19):5289-5306 doi:10.7150/thno.28228
Author contact
Corresponding authors
Published 2021-1-1
Citation styles
APA
Lu, J., Li, Y., Wu, Y., Zhou, S., Duan, C., Dong, Z., Kang, T., Tang, F. (2021). Retraction of “MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance”. Theranostics, 11(3), 1176. https://doi.org/10.7150/thno.55371.
ACS
Lu, J.; Li, Y.; Wu, Y.; Zhou, S.; Duan, C.; Dong, Z.; Kang, T.; Tang, F. Retraction of “MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance”. Theranostics 2021, 11 (3), 1176. DOI: 10.7150/thno.55371.
NLM
Lu J, Li Y, Wu Y, Zhou S, Duan C, Dong Z, Kang T, Tang F. Retraction of “MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance”. Theranostics 2021; 11(3):1176. doi:10.7150/thno.55371. https://www.thno.org/v11p1176.htm
CSE
Lu J, Li Y, Wu Y, Zhou S, Duan C, Dong Z, Kang T, Tang F. 2021. Retraction of “MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance”. Theranostics. 11(3):1176.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.